BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 20688245)

  • 1. Autoantibodies in ANCA-associated vasculitis.
    Wiik AS
    Rheum Dis Clin North Am; 2010 Aug; 36(3):479-89. PubMed ID: 20688245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Otolaryngologic manifestations of antineutrophil cytoplasmic antibody-associated vasculitis.
    Nakamaru Y; Takagi D; Oridate N; Homma A; Fukuda S
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):119-21. PubMed ID: 21987646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of ANCA-associated vasculitides.
    Kallenberg CG
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
    Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
    J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
    Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A
    Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
    Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
    Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L34. Neutrophils in ANCA-associated vasculitis: still under investigation.
    Witko-Sarsat V
    Presse Med; 2013 Apr; 42(4 Pt 2):595-7. PubMed ID: 23481359
    [No Abstract]   [Full Text] [Related]  

  • 11. ANCA: associated lung fibrosis.
    Yamada H
    Semin Respir Crit Care Med; 2011 Jun; 32(3):322-7. PubMed ID: 21674417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes.
    Wiik A
    Mod Rheumatol; 2009; 19(6):590-9. PubMed ID: 19730973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils are not consistently activated by antineutrophil cytoplasmic antibodies in vitro.
    Popat RJ; Robson MG
    Ann Rheum Dis; 2019 May; 78(5):709-711. PubMed ID: 30514699
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?
    Heeringa P; Huugen D; Tervaert JW
    Trends Immunol; 2005 Nov; 26(11):561-4. PubMed ID: 16139567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase 3 Autoreactivity in Anti-Neutrophil Cytoplasmic Antibody-associated vasculitis-Immunological versus clinical features.
    Sharma RK; Lövström B; Gunnarsson I; Malmström V
    Scand J Immunol; 2020 Nov; 92(5):e12958. PubMed ID: 32794199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
    Nakano H; Ozaki S
    Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiology and Laboratory Findings in Patients with ANCA-Associated Vasculitis].
    Wada T
    Rinsho Byori; 2015 Oct; 63(10):1213-9. PubMed ID: 26897859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope-specific anti-neutrophil cytoplasmic antibodies: do they matter? Can they be detected?
    Specks U
    APMIS Suppl; 2009 Jun; (127):63-6. PubMed ID: 19515143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
    Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
    Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.